eMediClear: clear medical answers based on reliable evidence

The description states that eMediClear is a Spanish-language educational health assistant available via Telegram. It operates by:

• Interpreting health questions in everyday language.
• Converting them into structured scientific queries.
• Searching PubMed and retrieving full-text articles from PubMed Central.
• Processing article content to extract relevant evidence.
• Generating claims based only on retrieved passages.
• Validating each claim against its supporting evidence.
• Rewriting validated information into clear, plain Spanish.
• Providing up to two traceable Vancouver-style references.

It is designed not to diagnose, prescribe, or replace professional care. Conversations remain isolated and can be deleted by users using the /forget command.

Inference The system appears to be an AI-powered research assistant for health literacy, intended for use in regions where misinformation is prevalent.

The description positions eMediClear as a tool that addresses the problem of health misinformation, particularly in developing regions like Latin America, where low health literacy and digital inequality contribute to poor health outcomes.

It claims to help users:

• Navigate confusing health information.
• Understand what scientific evidence supports or does not support.
• Avoid unsafe self-medication or delayed care.
• Have better-informed conversations with health professionals.

The project is framed as a solution that goes beyond generating more content — it aims to help people reach scientific evidence, understand it, and recognize its limitations without requiring medical training.

Inference This is a public health-oriented AI tool, positioned for use in underserved populations. It does not claim to be a clinical decision support system or diagnostic tool.

The description states that eMediClear targets users in developing regions like Latin America, where:

• Health literacy is low.
• Misinformation spreads quickly online.
• People often struggle to evaluate and understand health information.

It also implies a focus on users who:

• Search for symptoms or health concerns online.
• May be vulnerable due to age, socioeconomic status, or limited access to healthcare.
• Are not necessarily tech-savvy but are using digital tools like Telegram.

Inference The primary ICP is Spanish-speaking individuals in Latin America, especially those with low health literacy and high exposure to misinformation.

Not evidenced. The description does not mention any pricing model, monetization strategy, or business model.

The system is built using:

• OpenAI GPT-5.6 Sol as the primary reasoning engine.
• Codex for code generation and repository management.
• OpenAI Responses API for structured tasks.
• Structured Outputs with Pydantic schemas to enforce consistency.
• Text embeddings (text-embedding-3-large) for hybrid retrieval.
• A hybrid biomedical retrieval layer combining semantic and lexical methods.

Key technical decisions include:

• Separation of model-based reasoning from deterministic control (e.g., citation formatting, caching, privacy).
• Use of MeSH validation, full-text licensing checks, and numeric consistency verification.
• Isolation of conversations and idempotency in workflows.
• Integration with Telegram for delivery.

Inference The project shows a strong technical foundation rooted in AI and biomedical retrieval, but lacks evidence of production deployment or scalability beyond the hackathon context.

Not evidenced. There is no mention of:

• User engagement
• Customer acquisition
• Product usage metrics
• Real-world testing or feedback
• Deployment history

The project is described as a hackathon submission, built from scratch using AI tools, without any indication of prior traction.

Not evidenced. The description does not reference existing competitors or similar products in the health information space.

1. No real-world usage or testing: The project is described as a hackathon submission with no evidence of user engagement or deployment.
2. Unverified safety boundaries: While it claims to avoid diagnosis and prescription, there is no evidence that these safety limits are enforced in practice.
3. Limited scope for scalability: The system is built for a single language (Spanish) and platform (Telegram), with no indication of expansion plans.
4. Dependency on external APIs: Reliance on PubMed and PubMed Central may limit availability or introduce latency.
5. Lack of commercialization strategy: No mention of monetization, partnerships, or go-to-market plans.

1. Has the bot been tested with real users in Latin America?
2. What is the current state of user engagement or feedback?
3. How does the system handle edge cases or ambiguous inputs?
4. Are there any legal or ethical considerations around deploying such a tool in healthcare settings?
5. What are the plans for scaling beyond the hackathon prototype?
6. Is there any plan to expand beyond Spanish or Telegram?